Primary Lung Cancer After Treatment for Breast Cancer

References

• DiMarzio P, Peila R, Dowling O, et al. Smoking and alcohol drinking effect on radiotherapy associated risk of second primary cancer and mortality among breast cancer patients. Cancer Epidemiol. 2018;57::97–103. doi:10.1016/j.canep.2018.10.002
   Web of Science ®Google Scholar
• Huang YJ, Huang TW, Lin FH, Chung CH, Tsao CH, Chien WC. Radiation therapy for invasive breast cancer increases the risk of second primary lung cancer: a nationwide population-based cohort analysis. J Thoracic Oncol. 2017;12(5):782–790. doi:10.1016/j.jtho.2017.01.021
   Web of Science ®Google Scholar
• Withrow DR, Morton LM, Curtis RE, Schonfeld SJ, Berrington de González A. Radiotherapy for ductal carcinoma in situ and risk of second non-breast cancers. Breast Cancer Res Treat. 2017;166(1):299–306. doi:10.1007/s10549-017-4410-6
   Web of Science ®Google Scholar
• Mellemkjaer L, Friis S, Olsen JH, et al. Risk of second cancer among women with breast cancer. Int J Cancer. 2005;118(9):2285–2292. doi:10.1002/ijc.21651
   Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.21590
   PubMed Web of Science ®Google Scholar
• Lorigan P, Radford J, Howell A, Thatcher N. Lung cancer after treatment for Hodgkin’s lymphoma: a systematic review. Lancet Oncol. 2005;6(10):773–779. doi:10.1016/S1470-2045(05)70387-9
   Web of Science ®Google Scholar
• Ford MB, Sigurdson AJ, Petrulis ES, et al. Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors. Cancer. 2003;98(7):1457–1464. doi:10.1002/cncr.11669
   PubMed Web of Science ®Google Scholar
• Kaufman EL, Jacobson JS, Hershman DL, Desai M, Neugut AI. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol. 2008;26(3):392–398. doi:10.1200/JCO.2007.13.3033
   Web of Science ®Google Scholar
• Wang R, Yin Z, Liu L, et al. Second primary lung cancer after breast cancer: a population-based study of 6269 women. Front Oncol. 2018;8:427. doi:10.3389/fonc.2018.00427
   PubMed Web of Science ®Google Scholar
• Liu J, Hu Z, Feng Y, Zeng S, Zhong M. Problems to affect long-term survival for breast cancer patients: an observational study of subsequent lung/bronchus malignancies. Medicine. 2018;97(39):e12603. doi:10.1097/MD.0000000000012603
   Web of Science ®Google Scholar
• Utada M, Ohno Y, Hori M, Soda M. Incidence of multiple primary cancers and interval between first and second primary cancers. Cancer Sci. 2014;105(7):890–896. doi:10.1111/cas.12433
   Web of Science ®Google Scholar
• Evans HS, Lewis CM, Robinson D, Bell CM, Møller H, Hodgson SV. Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England. Br J Cancer. 2001;84(3):435–440. doi:10.1054/bjoc.2000.1603
   PubMed Web of Science ®Google Scholar
• Schaapveld M, Visser O, Louwman MJ, et al. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. J Clin Oncol. 2008;26(8):1239–1246. doi:10.1200/JCO.2007.11.9081
   PubMed Web of Science ®Google Scholar
• Dörffel WV, Reitzig P, Dörffel Y, Possinger K. [Secondary malignant neoplasms in patients with breast cancer]. Zentralbl Gynakol. 2000;122(8):419–427. doi:10.1055/s-2000-10604
   Google Scholar
• Rubino C, de Vathaire F, Diallo I, Shamsaldin A, Lê MG. Increased risk of second cancers following breast cancer: role of the initial treatment. Breast Cancer Res Treat. 2000;61(3):183–195.doi:10.1023/a:1006489918700
   Google Scholar
• Levi F, Te VC, Randimbison L, La Vecchia C. Cancer risk in women with previous breast cancer. Ann Oncol. 2003;14(1):71–73.doi:10.1093/annonc/mdg028
   Google Scholar
• Lee KD, Chen SC, Chan CH, et al. Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan. Cancer Epidemiol Biomarkers Prev. 2008;17(10):2647–2655. doi:10.1158/1055-9965.epi-08-0109
   Google Scholar
• Rosso S, Terracini L, Ricceri F, Zanetti R. Multiple primary tumours: incidence estimation in the presence of competing risks. Popul Health Metr. 2009;7:5. doi:10.1186/1478-7954-7-5
   Google Scholar
• Yi M, Cormier JN, Xing Y, et al. Other primary malignancies in breast cancer patients treated with breast conserving surgery and radiation therapy. Ann Surg Oncol. 2013;20(5):1514–1521. doi:10.1245/s10434-012-2774-8
   Google Scholar
• Hamilton SN, Tyldesley S, Li D, Olson R, McBride M. Second malignancies after adjuvant radiation therapy for early stage breast cancer: is there increased risk with addition of regional radiation to local radiation? Int J Radiat Oncol Biol Phys. 2015;91(5):977–985. doi:10.1016/j.ijrobp.2014.12.051
   Google Scholar
• Bazire L, De Rycke Y, Asselain B, Fourquet A, Kirova YM. Risks of second malignancies after breast cancer treatment: Long-term results. Cancer Radiother. 2017;21(1):10–15. doi:10.1016/j.canrad.2016.07.101
   Google Scholar
• Silverman BG, Lipshitz I, Keinan-Boker L. Second Primary Cancers After Primary Breast Cancer Diagnosis in Israeli Women, 1992 to 2006. J Glob Oncol. 2017;3(2):135–142. doi:10.1200/jgo.2016.003699
   Google Scholar
• Lin EP, Lin CH, Yang CY, et al. Population-Based Cohort Study Reveals Distinct Associations Between Female Lung Cancer and Breast Cancer in Taiwan. JCO Clin Cancer Inform. 2018;2:1–14. doi:10.1200/cci.18.00065
   Google Scholar
• O'Keeffe LM, Taylor G, Huxley RR, Mitchell P, Woodward M, Peters SAE. Smoking as a risk factor for lung cancer in women and men: a systematic review and meta-analysis. BMJ Open. 2018;8(10):e021611. doi:10.1136/bmjopen-2018-021611
   Google Scholar
• Stathopoulos GT, Sherrill TP, Cheng DS, et al. Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis. Proc Natl Acad Sci U S A. 2007;104(47):18514–18519. doi:10.1073/pnas.0705316104
   Google Scholar
• Campbell JD, Alexandrov A, Kim J, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016;48(6):607–616. doi:10.1038/ng.3564
   Google Scholar
• Neugut AI, Murray T, Santos J, et al. Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers. Cancer. 1994;73(6):1615–1620. doi:10.1002/1097-0142(19940315)73:6<1615::aid-cncr2820730612>3.0.co;2-6
   Google Scholar
• Obedian E, Fischer DB, Haffty BG. Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy. J Clin Oncol. 2000;18(12):2406–2412. doi:10.1200/jco.2000.18.12.2406
   Google Scholar
• Zablotska LB, Neugut AI. Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma. Cancer. 2003;97(6):1404–1411. doi:10.1002/cncr.11214
   Google Scholar
• Deutsch M, Land SR, Begovic M, Wieand HS, Wolmark N, Fisher B. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06. Cancer. 2003;98(7):1362–1368. doi:10.1002/cncr.11655
   Google Scholar
• Roychoudhuri R, Evans H, Robinson D, Møller H. Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer. 2004;91(5):868–872. doi:10.1038/sj.bjc.6602084
   Google Scholar
• Levi F, Randimbison L, Te VC, La Vecchia C. Cancer risk after radiotherapy for breast cancer. Br J Cancer. 2006;95(3):390–392. doi:10.1038/sj.bjc.6603235
   Google Scholar
• Andersson M, Jensen MB, Engholm G, Henrik Storm H. Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001. Acta Oncol. 2008;47(4):755–764. doi:10.1080/02841860801978921
   Google Scholar
• Zhong M, He X, Lei K. Survival of Patients with First and Metachronous Second Primary Breast Cancer or Lung Cancer Malignancy: Comparisons Using the SEER Database. Adv Ther. 2020;37(5):2236–2245. doi:10.1007/s12325-020-01322-0
   Google Scholar
• Li D, Weng S, Zhong C, et al. Risk of Second Primary Cancers Among Long-Term Survivors of Breast Cancer. Front Oncol. 2019;9:1426. doi:10.3389/fonc.2019.01426
   Google Scholar
• Buumba BM, Bhardwaj S, Kaur P. A Critical Review on Recent Development of Techniques and Drug Targets in the Management of Breast Cancer. Mini Rev Med Chem. 2021;21(15):2103–2129. doi:10.2174/1389557521666210126125200
   Google Scholar
• Pathak M, Deo SV, Dwivedi SN, Thakur B, Sreenivas V, Rath GK. Regimens of neo-adjuvant chemotherapy in the treatment of breast cancer: A systematic review & network meta-analysis with PRISMA-NMA compliance. Crit Rev Oncol Hematol. 2020;153:103015. doi:10.1016/j.critrevonc.2020.103015
   Google Scholar
• Tan W, Li Q, Chen K, Su F, Song E, Gong C. Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis. Oncotarget. 2016;7(9):10373–10385. doi:10.18632/oncotarget.7219
   Google Scholar
• Boland MR, Ryan É J, Dunne E, Aherne TM, Bhatt NR, Lowery AJ. Meta-analysis of the impact of progesterone receptor status on oncological outcomes in oestrogen receptor-positive breast cancer. Br J Surg. 2020;107(1):33–43. doi:10.1002/bjs.11347
   Google Scholar
• Guo H, Wei B, Zhang HY, et al. [HER2 expression and its prognostic implication in lymph node negative breast carcinoma: a Meta-analysis]. Zhonghua Bing Li Xue Za Zhi. 2005;34(3):140–146
   Google Scholar
• Skjefstad K, Richardsen E, Donnem T, et al. The prognostic role of progesterone receptor expression in non-small cell lung cancer patients: Gender-related impacts and correlation with disease-specific survival. Steroids. 2015;98:29–36. doi:10.1016/j.steroids.2015.01.020
   Google Scholar
• Hsu LH, Chu NM, Kao SH. Estrogen, Estrogen Receptor and Lung Cancer. Int J Mol Sci. 2017;18(8). doi:10.3390/ijms18081713
   Google Scholar
• Skjefstad K, Grindstad T, Khanehkenari MR, et al. Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer. Steroids. 2016;113:5–13. doi:10.1016/j.steroids.2016.05.008
   Google Scholar
• Meert AP, Martin B, Paesmans M, et al. The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature. Br J Cancer. 2003;89(6):959–965. doi:10.1038/sj.bjc.6601252
   Google Scholar
• K J, F L, M L. Association between high expression of ERα and ERβ and non-small cell lung cancer. J Shanxi Med Univ. 2019;50(02):181–188.
   Google Scholar
• Clague J, Reynolds P, Sullivan-Halley J, et al. Menopausal hormone therapy does not influence lung cancer risk: results from the California Teachers Study. Cancer Epidemiol Biomarkers Prev. 2011;20(3):560–564. doi:10.1158/1055-9965.epi-10-1182
   Google Scholar
• Pesatori AC, Carugno M, Consonni D, et al. Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO). Br J Cancer. 2013;109(7):1954–1964. doi:10.1038/bjc.2013.506
   Google Scholar
• Chen YY, Huang YJ, Huang HK, et al. The prognostic factors of recurrence and survival in female patients with lung adenocarcinoma and breast cancer. J Cancer Res Clin Oncol. 2020;146(5):1299–1306. doi:10.1007/s00432-020-03162-5
   Google Scholar